Platelet‐rich plasma improves acute and chronic anal fissure, a randomized control trial

Anal fissure is one of the most prevalent diagnosis in patients with anorectal symptoms. Depending on the chronicity, treatment choices vary, from topical and conservative management to operative ones. PRP is a blood‐derived product with a three to five‐fold platelet count and can be used for restor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Wound repair and regeneration 2023-09, Vol.31 (5), p.655-662
Hauptverfasser: Ebrahimibagha, Hamed, Zeinalpour, Adel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 662
container_issue 5
container_start_page 655
container_title Wound repair and regeneration
container_volume 31
creator Ebrahimibagha, Hamed
Zeinalpour, Adel
description Anal fissure is one of the most prevalent diagnosis in patients with anorectal symptoms. Depending on the chronicity, treatment choices vary, from topical and conservative management to operative ones. PRP is a blood‐derived product with a three to five‐fold platelet count and can be used for restorative purposes. The objective of this study is to assess the therapeutic effect of intralesional PRP in acute and chronic anal fissures and comparing it with the classic topical approach. We included 94 patients with acute and chronic anal fissures and divided them into intervention and control groups. Control patients were treated only with topical compounds, and the intervention group received one dose of intralesional autologous PRP plus the same classic treatment. We assessed patients 2 weeks, 1 month, and 6 months later. The mean pain score in the intervention group was significantly lower than control groups in all visits (p‐value
doi_str_mv 10.1111/wrr.13103
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2828363723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2828363723</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2853-e8748d1348d3fac62622488d21252c670d23823c0b0700962866c8c713e06b5d3</originalsourceid><addsrcrecordid>eNp1kEtKA0EQhhtRTIwuvID0UsFJ-jH9yFKCLwgoQVFwMXR6ekhLTyZ2zxjiyiN4BM_iUTyJrRPdWYuqgvr4KH4A9jHq41iDpfd9TDGiG6CLGUmTVLD7zbgjLhI8JKIDdkJ4RAgxNpTboEMFTRHDaRc8XDtVG2fqz9c3b_UMLpwKpYK2XPjq2QSodFMbqOY51DNfza2Ou3KwsCE03hxDBX08VqV9MfnHu67mta8crL1VbhdsFcoFs7eePXB7dnozukjGV-eXo5NxoolkNDFSpDLHNDZaKM0JJySVMieYMKK5QDmhklCNpkggNOREcq6lFpgaxKcspz1w2Hrjy0-NCXVW2qCNc2puqiZkRBJJORWERvSoRbWvQvCmyBbelsqvMoyy7yyzmGX2k2VkD9baZlqa_I_8DS8CgxZYWmdW_5uyu8mkVX4BZS1-2g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2828363723</pqid></control><display><type>article</type><title>Platelet‐rich plasma improves acute and chronic anal fissure, a randomized control trial</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Ebrahimibagha, Hamed ; Zeinalpour, Adel</creator><creatorcontrib>Ebrahimibagha, Hamed ; Zeinalpour, Adel</creatorcontrib><description>Anal fissure is one of the most prevalent diagnosis in patients with anorectal symptoms. Depending on the chronicity, treatment choices vary, from topical and conservative management to operative ones. PRP is a blood‐derived product with a three to five‐fold platelet count and can be used for restorative purposes. The objective of this study is to assess the therapeutic effect of intralesional PRP in acute and chronic anal fissures and comparing it with the classic topical approach. We included 94 patients with acute and chronic anal fissures and divided them into intervention and control groups. Control patients were treated only with topical compounds, and the intervention group received one dose of intralesional autologous PRP plus the same classic treatment. We assessed patients 2 weeks, 1 month, and 6 months later. The mean pain score in the intervention group was significantly lower than control groups in all visits (p‐value &lt;0.001). During the follow‐ups, the bleeding rate was significantly lower in the intervention group, so in the sixth month, the bleeding was 4% in the intervention group against 32% of the control (p‐value &lt;0.001). The healing rate assessed by examination was 96% in the intervention group against 66% in the control in the sixth month (p‐value &lt;0.001). Although there may be no significant difference in healing rate between groups in the acute anal fissure, the PRP group is significantly superior in the chronic setting. We concluded that in anal fissure treatment, PRP plus topical products are significantly superior to alone topical treatment.</description><identifier>ISSN: 1067-1927</identifier><identifier>ISSN: 1524-475X</identifier><identifier>EISSN: 1524-475X</identifier><identifier>DOI: 10.1111/wrr.13103</identifier><identifier>PMID: 37340514</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Administration, Topical ; anal fissure ; calcium channel blocker ; Chronic Disease ; Fissure in Ano - drug therapy ; Fissure in Ano - surgery ; Humans ; lateral internal sphincterotomy ; platelet rich plasma (PRP) ; Platelet-Rich Plasma ; Treatment Outcome ; Wound Healing</subject><ispartof>Wound repair and regeneration, 2023-09, Vol.31 (5), p.655-662</ispartof><rights>2023 The Wound Healing Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2853-e8748d1348d3fac62622488d21252c670d23823c0b0700962866c8c713e06b5d3</cites><orcidid>0000-0001-9848-2754</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fwrr.13103$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fwrr.13103$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37340514$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ebrahimibagha, Hamed</creatorcontrib><creatorcontrib>Zeinalpour, Adel</creatorcontrib><title>Platelet‐rich plasma improves acute and chronic anal fissure, a randomized control trial</title><title>Wound repair and regeneration</title><addtitle>Wound Repair Regen</addtitle><description>Anal fissure is one of the most prevalent diagnosis in patients with anorectal symptoms. Depending on the chronicity, treatment choices vary, from topical and conservative management to operative ones. PRP is a blood‐derived product with a three to five‐fold platelet count and can be used for restorative purposes. The objective of this study is to assess the therapeutic effect of intralesional PRP in acute and chronic anal fissures and comparing it with the classic topical approach. We included 94 patients with acute and chronic anal fissures and divided them into intervention and control groups. Control patients were treated only with topical compounds, and the intervention group received one dose of intralesional autologous PRP plus the same classic treatment. We assessed patients 2 weeks, 1 month, and 6 months later. The mean pain score in the intervention group was significantly lower than control groups in all visits (p‐value &lt;0.001). During the follow‐ups, the bleeding rate was significantly lower in the intervention group, so in the sixth month, the bleeding was 4% in the intervention group against 32% of the control (p‐value &lt;0.001). The healing rate assessed by examination was 96% in the intervention group against 66% in the control in the sixth month (p‐value &lt;0.001). Although there may be no significant difference in healing rate between groups in the acute anal fissure, the PRP group is significantly superior in the chronic setting. We concluded that in anal fissure treatment, PRP plus topical products are significantly superior to alone topical treatment.</description><subject>Administration, Topical</subject><subject>anal fissure</subject><subject>calcium channel blocker</subject><subject>Chronic Disease</subject><subject>Fissure in Ano - drug therapy</subject><subject>Fissure in Ano - surgery</subject><subject>Humans</subject><subject>lateral internal sphincterotomy</subject><subject>platelet rich plasma (PRP)</subject><subject>Platelet-Rich Plasma</subject><subject>Treatment Outcome</subject><subject>Wound Healing</subject><issn>1067-1927</issn><issn>1524-475X</issn><issn>1524-475X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtKA0EQhhtRTIwuvID0UsFJ-jH9yFKCLwgoQVFwMXR6ekhLTyZ2zxjiyiN4BM_iUTyJrRPdWYuqgvr4KH4A9jHq41iDpfd9TDGiG6CLGUmTVLD7zbgjLhI8JKIDdkJ4RAgxNpTboEMFTRHDaRc8XDtVG2fqz9c3b_UMLpwKpYK2XPjq2QSodFMbqOY51DNfza2Ou3KwsCE03hxDBX08VqV9MfnHu67mta8crL1VbhdsFcoFs7eePXB7dnozukjGV-eXo5NxoolkNDFSpDLHNDZaKM0JJySVMieYMKK5QDmhklCNpkggNOREcq6lFpgaxKcspz1w2Hrjy0-NCXVW2qCNc2puqiZkRBJJORWERvSoRbWvQvCmyBbelsqvMoyy7yyzmGX2k2VkD9baZlqa_I_8DS8CgxZYWmdW_5uyu8mkVX4BZS1-2g</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>Ebrahimibagha, Hamed</creator><creator>Zeinalpour, Adel</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9848-2754</orcidid></search><sort><creationdate>202309</creationdate><title>Platelet‐rich plasma improves acute and chronic anal fissure, a randomized control trial</title><author>Ebrahimibagha, Hamed ; Zeinalpour, Adel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2853-e8748d1348d3fac62622488d21252c670d23823c0b0700962866c8c713e06b5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Administration, Topical</topic><topic>anal fissure</topic><topic>calcium channel blocker</topic><topic>Chronic Disease</topic><topic>Fissure in Ano - drug therapy</topic><topic>Fissure in Ano - surgery</topic><topic>Humans</topic><topic>lateral internal sphincterotomy</topic><topic>platelet rich plasma (PRP)</topic><topic>Platelet-Rich Plasma</topic><topic>Treatment Outcome</topic><topic>Wound Healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ebrahimibagha, Hamed</creatorcontrib><creatorcontrib>Zeinalpour, Adel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Wound repair and regeneration</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ebrahimibagha, Hamed</au><au>Zeinalpour, Adel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Platelet‐rich plasma improves acute and chronic anal fissure, a randomized control trial</atitle><jtitle>Wound repair and regeneration</jtitle><addtitle>Wound Repair Regen</addtitle><date>2023-09</date><risdate>2023</risdate><volume>31</volume><issue>5</issue><spage>655</spage><epage>662</epage><pages>655-662</pages><issn>1067-1927</issn><issn>1524-475X</issn><eissn>1524-475X</eissn><abstract>Anal fissure is one of the most prevalent diagnosis in patients with anorectal symptoms. Depending on the chronicity, treatment choices vary, from topical and conservative management to operative ones. PRP is a blood‐derived product with a three to five‐fold platelet count and can be used for restorative purposes. The objective of this study is to assess the therapeutic effect of intralesional PRP in acute and chronic anal fissures and comparing it with the classic topical approach. We included 94 patients with acute and chronic anal fissures and divided them into intervention and control groups. Control patients were treated only with topical compounds, and the intervention group received one dose of intralesional autologous PRP plus the same classic treatment. We assessed patients 2 weeks, 1 month, and 6 months later. The mean pain score in the intervention group was significantly lower than control groups in all visits (p‐value &lt;0.001). During the follow‐ups, the bleeding rate was significantly lower in the intervention group, so in the sixth month, the bleeding was 4% in the intervention group against 32% of the control (p‐value &lt;0.001). The healing rate assessed by examination was 96% in the intervention group against 66% in the control in the sixth month (p‐value &lt;0.001). Although there may be no significant difference in healing rate between groups in the acute anal fissure, the PRP group is significantly superior in the chronic setting. We concluded that in anal fissure treatment, PRP plus topical products are significantly superior to alone topical treatment.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37340514</pmid><doi>10.1111/wrr.13103</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9848-2754</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1067-1927
ispartof Wound repair and regeneration, 2023-09, Vol.31 (5), p.655-662
issn 1067-1927
1524-475X
1524-475X
language eng
recordid cdi_proquest_miscellaneous_2828363723
source MEDLINE; Wiley Online Library All Journals
subjects Administration, Topical
anal fissure
calcium channel blocker
Chronic Disease
Fissure in Ano - drug therapy
Fissure in Ano - surgery
Humans
lateral internal sphincterotomy
platelet rich plasma (PRP)
Platelet-Rich Plasma
Treatment Outcome
Wound Healing
title Platelet‐rich plasma improves acute and chronic anal fissure, a randomized control trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T01%3A30%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Platelet%E2%80%90rich%20plasma%20improves%20acute%20and%20chronic%20anal%20fissure,%20a%20randomized%C2%A0control%20trial&rft.jtitle=Wound%20repair%20and%20regeneration&rft.au=Ebrahimibagha,%20Hamed&rft.date=2023-09&rft.volume=31&rft.issue=5&rft.spage=655&rft.epage=662&rft.pages=655-662&rft.issn=1067-1927&rft.eissn=1524-475X&rft_id=info:doi/10.1111/wrr.13103&rft_dat=%3Cproquest_cross%3E2828363723%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2828363723&rft_id=info:pmid/37340514&rfr_iscdi=true